The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a Stage IV NSCLC care pathway on front-line (FL) and maintenance (M) chemotherapy use at the Cleveland Clinic Taussig Cancer Institute (TCI).
 
Marc A. Shapiro
No Relationships to Disclose
 
James Stevenson
Research Funding - Merck Sharp & Dohme (Inst); Verastem (Inst)
 
Emily Van Wagoner
No Relationships to Disclose
 
Katherine Glass
Research Funding - Pinnacle Biologics
 
Chad W Cummings
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - Genentech
Research Funding - Astex Pharmaceuticals (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Newlink Genetics (Inst)
 
Patrick C. Ma
No Relationships to Disclose
 
Vamsidhar Velcheti
No Relationships to Disclose
 
Bruno R. Bastos
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - Boehringer Ingelheim
 
Brian James Bolwell
No Relationships to Disclose
 
Abdo Haddad
No Relationships to Disclose